GRAIL Inc

GRAL

Market cap $3.12B

New York, New York--(Newsfile Corp. - July 17, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ: GRAL) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Grail securities between May 13, 2025 and February 19, 2026, both dates inclusive (the "Class Period").

SAN FRANCISCO, July 17, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is investigating claims in a pending class action alleging violations of U.S. securities laws by GRAIL, Inc. (NASDAQ: GRAL). The suit contends the company misled investors regarding the clinical design and efficacy of its landmark NHS-Galleri cancer screening trial.

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of GRAIL, Inc. (NASDAQ: GRAL).

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (NASDAQ:GRAL) and certain of the Company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws. If you invested in GRAIL, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/grail-class-action-lawsuit.

New York, New York--(Newsfile Corp. - July 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the "Class Period"), of the important August 4, 2026 lead plaintiff deadline. SO WHAT: If you purchased GRAIL common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New class action for Grail, Inc. (GRAL) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/4/2026

Time-Sensitive: Allegations Focus on Defendants' Refusal to Share Detailed NHS-Galleri Data, Potentially Concealing Adverse Trendlines From Investors NEW YORK, July 16, 2026 /PRNewswire/ -- SueWallSt alerts investors in Grail, Inc. (NASDAQ: GRAL) of a pending securities class action. Class Period: May 13, 2025 through February 19, 2026.

NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. ("Grail" or the "Company") (NASDAQ: GRAL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Philadelphia, Pennsylvania--(Newsfile Corp. - July 16, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL) ("GRAIL" or the "Company") on behalf of investors who purchased or acquired GRAIL common stock during the period from May 13, 2025 through February 19, 2026 (the "Class Period"). Investor Deadline: Investors who purchased or acquired GRAIL common stock during the Class Period may, no later than August 4, 2026, seek to be appointed as a lead plaintiff representative of the class.

NEW YORK, July 16, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds GRAIL, Inc. (“GRAIL” or the “Company”) (NASDAQ: GRAL) investors of the  August 4, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The GRAIL Class Action Lawsuit : Do you, or did you, own shares of GRAIL, Inc. (NASDAQ: GRAL)?